|

Tucatinib Oral Tablet Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

  • UNICANCER1

Indications

  • Leptomeningeal Disease1
  • HER2-positive Metastatic Breast Cancer1
  • Breast Cancer1
  • Leptomeningeal Metastasis1
  • Cancer1

Other1 trial

Capecitabine, Tucatinib, and Intrathecal Trastuzumab for Breast Cancer Patients With Leptomeningeal Disease
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.